The partner pilot
For independent PMX and clinical pharmacology consultants, one to five people, who want to take on more studies without hiring.
Where the week goes
Most consultants we talk to work alone or in a team of two, with their own licences and their own way of doing each analysis. Most of the week goes to files, datasets and back-and-forth with the client. That caps a practice at one or two clients at a time.
Zynthari takes that work on, so the same team can run more studies.
Who does what
| Responsibility | You | Zynthari |
|---|---|---|
| The client relationship | Owns | |
| Scientific judgment and interpretation | Leads | |
| Sign-off on every result | Signs | |
| Analysis-ready datasets | Builds | |
| A standard workflow for each analysis, in Studio | Provides | |
| QC and version control on every script; your GitHub can be connected | Runs | |
| A separate workspace for each client | Provides | |
| Infrastructure and its maintenance | Operates |
Zynthari doesn't handle your billing or your admin.
Where it runs
- Our managed workspace
- An isolated workspace for each client, run by us. There is nothing for you to set up, and this is how pilots run.
- Your client's own cloud
- Studio runs inside the client's cloud account, with the same workflow, scripts and record.
How a pilot runs
- A call about your practiceWe pick one study you want to run, with a client who is happy to take part.
- An NDA and a workspaceWe sign an NDA and set up a separate workspace for that client.
- The dataset firstWe build the analysis-ready dataset with you and resolve every flag before the analysis starts.
- The analysis in StudioYou run the analysis on a standard workflow, with our team alongside, and you sign off the result.
- A review togetherWhat saved you time, what didn't, and whether to carry on.
Pricing
We agree pricing with each partner. Ask us about it on the first call.
Apply for the pilot.
Tell us about your practice and the study you'd like to start with.
Or email intakezynthari@gmail.com.
Thank you.
Your request reached us. We'll reply to .